The state-owned company bought about 1.4 million shares of WeRide and 14,500 shares of Pony.ai in the September quarter, according…
Read More »BeOne Medicines
The ferocity of China’s biopharmaceutical investment boom this year – fuelled by record-breaking licensing of commercial rights to global giants…
Read More »
BeOne Medicines, a global drug company that originated in mainland China, plans to launch more cancer drugs in Hong Kong…
Read More »
Shares of Chinese drug firm Akeso – likened by some Western media outlets to artificial intelligence start-up DeepSeek – rose…
Read More »
The Chinese pharmaceutical sector has significantly outperformed the broader market this year, driven by strong sales growth and a rapid…
Read More »
Chinese Premier Li Qiang has called for stronger policy support for the biotech industry, as part of efforts to bolster…
Read More »